Novanta Inc. NOVT
- Market cap
- $5.4B
- P/E
- 90.6×
Follow NOVT
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.23 | 20.70 | 48.40 | 60.15 | 66.44 | 116.55 | 110.84 | 111.20 | 146.86 | 98.27 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 21.75 | 55.10 | 78.85 | 96.31 | 127.91 | 184.44 | 177.11 | 187.61 | 187.12 | 155.39 |
High Price
|
|||
| 1,269 | 2,034 | 2,133 | 2,290 | 2,200 | 2,700 | 3,000 | 2,900 | 3,000 | 3,000 |
Employees
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| 385 | 521 | 614 | 626 | 591 | 707 | 861 | 882 | 949 | 981 |
Revenue
|
|||
| 42.22% | 42.30% | 42.57% | 41.86% | 41.40% | 42.49% | 43.96% | 45.36% | 44.41% | 44.39% |
Gross Margin
|
|||
| 33 | 76 | 61 | 46 | 48 | 56 | 87 | 84 | 79 | 70 |
EBT
|
|||
| 8.45% | 14.60% | 9.98% | 7.31% | 8.20% | 7.95% | 10.12% | 9.50% | 8.33% | 7.10% |
EBT Margin
|
|||
| 22 | 62 | 51 | 41 | 45 | 50 | 74 | 73 | 64 | 54 |
Net Income
|
|||
| 20 | 31 | 37 | 38 | 38 | 43 | 53 | 47 | 56 | 62 |
Depreciation
|
|||
| 11.09 | 14.97 | 17.60 | 17.87 | 16.81 | 19.97 | 24.15 | 24.60 | 26.40 | 26.80 |
Revenue/Sh
|
|||
| 0.63 | 1.14 | 1.46 | 1.16 | 1.27 | 1.42 | 2.08 | 2.03 | 1.78 | 1.47 |
Earnings/Sh
|
|||
| 1.38 | 1.82 | 2.57 | 1.81 | 3.99 | 2.67 | 2.55 | 3.35 | 4.41 | 1.75 |
Cash Flow/Sh
|
|||
| (0.16) | (0.26) | (0.46) | (0.31) | (0.30) | (0.56) | (0.55) | (0.56) | (0.48) | (0.43) |
Capex/Sh
|
|||
| 1.22 | 1.56 | 2.11 | 1.50 | 3.69 | 2.11 | 2.00 | 2.79 | 3.93 | 1.32 |
Free CF/Sh
|
|||
| 7.46 | 8.95 | 10.55 | 11.91 | 13.57 | 14.73 | 16.20 | 18.79 | 20.74 | 35.92 |
Book Value/Sh
|
|||
| 35 | 35 | 35 | 35 | 35 | 35 | 36 | 36 | 36 | 37 |
Shares
|
|||
| 34.21 | 43.91 | 43.52 | 76.24 | 93.83 | 124.18 | 64.82 | 80.94 | 85.83 | 80.95 |
PE Ratio
|
|||
| 1.94 | 3.37 | 3.58 | 4.95 | 7.03 | 8.83 | 5.58 | 6.68 | 5.79 | 4.44 |
PS Ratio
|
|||
| 2.89 | 5.64 | 5.97 | 7.43 | 8.71 | 11.97 | 8.32 | 8.74 | 7.37 | 3.31 |
PB Ratio
|
|||
| 1.97 | 3.63 | 3.78 | 5.17 | 7.16 | 9.28 | 5.97 | 6.96 | 6.10 | 4.31 |
EV/Sales
|
|||
| 17.87 | 34.84 | 31.56 | 61.65 | 32.61 | 87.62 | 72.15 | 61.32 | 41.00 | 87.21 |
EV/FCF
|
|||
| 48 | 63 | 90 | 63 | 140 | 95 | 91 | 120 | 159 | 64 |
Op' Cash Flow
|
|||
| (5) | (9) | (16) | (11) | (11) | (20) | (20) | (20) | (17) | (16) |
Capex
|
|||
| 42 | 54 | 74 | 53 | 130 | 75 | 71 | 100 | 141 | 48 |
FCF
|
|||
| 129 | 190 | 178 | 170 | 190 | 190 | 256 | 276 | 266 | 570 |
Working Cap'
|
|||
| 78 | 235 | 207 | 220 | 200 | 434 | 435 | 354 | 417 | 251 |
Total Debt
|
|||
| 10 | 135 | 125 | 141 | 75 | 317 | 335 | 249 | 303 | (130) |
Net Debt
|
|||
| 259 | 312 | 368 | 417 | 477 | 521 | 578 | 673 | 746 | 1,314 |
Sh' Equity
|
|||
| 5.23% | 6.91% | 7.04% | 5.13% | 5.13% | 4.81% | 6.00% | 5.91% | 4.90% | 3.37% |
ROA
|
|||
| 7.67% | 8.07% | 8.99% | 6.19% | 6.33% | 4.78% | 7.06% | 7.48% | 6.59% | 4.96% |
ROIC
|
|||
| 8.74% | 13.96% | 14.97% | 10.38% | 9.96% | 10.09% | 13.48% | 11.65% | 9.03% | 5.23% |
ROE
|
|||
Novanta Inc. peers in Scientific & Technical Instruments
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| ST Sensata Technologies Holding N.V. | $6.0B | 69.2× | Compare |
| VNT Vontier Corporation | $4.2B | 13.0× | Compare |
| ESE ESCO Technologies Inc. | $7.0B | 22.1× | Compare |
| ITRI Itron, Inc. | $4.0B | 14.8× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| BMI Badger Meter, Inc. | $3.8B | 30.2× | Compare |
| CGNX Cognex Corporation | $9.8B | 55.9× | Compare |
| TRMB Trimble Inc. | $13.5B | 0.0× | Compare |
| FTV Fortive Corporation | $16.7B | 32.6× | Compare |
Novanta Inc. (NOVT) key facts
- Novanta Inc. (NOVT) is a Scientific & Technical Instruments company in the Technology sector, listed on Nasdaq.
- Novanta Inc.’s revenue for fiscal 2025 (year ended December 2025) was $980.6 million, up 3.30% from fiscal 2024.
- As of September 25, 2026, NOVT traded at $143.93, a market capitalization of $5.4 billion.
- Return on equity was 5.23% and debt-to-equity 0.14.
Novanta Inc. (NOVT) Latest News
19 Sep
Novanta (NOVT) shows strong growth and positive demand outlook, prompting assessment of whether the stock represents a bargain at current levels. Strong growth and demand outlook supports moderately positive effects on future financial performance and investor sentiment.
Novanta Inc. (NOVT) shows high-margin revenue momentum that may strengthen its competitive moat. Revenue momentum can moderately influence Novanta's competitive positioning and performance outlook.
4 Sep
Novanta Inc. posted second-quarter profits that outran sales growth. Q2 profit growth exceeding sales can lift near-term investor views on margins but rarely shifts long-term trajectory.
14 Aug
Novanta Inc. discussed five key analyst questions during its Q2 earnings call, covering operational performance, strategic priorities and market outlook. Analyst questions from the Q2 earnings call reveal operational and strategic details that can moderately shape near-term investor views on Novanta.
13 Aug
Novanta Inc. conducted its Q2 2026 earnings call, detailing financial results, operational performance, and forward-looking guidance for investors. Quarterly earnings details typically influence short-term stock sentiment and analyst views without guaranteeing major strategic shifts.
10 Aug
Novanta Inc. completed acquisitions and advanced manufacturing initiatives during Q2, resulting in an upgraded company outlook. Acquisitions and manufacturing moves represent major strategic actions likely to shift Novanta's trajectory and investor sentiment.
9 Aug
Novanta raised financial guidance and closed its Riverpoint facility, prompting questions on whether the positive moves are already reflected in the stock price. Guidance increase signals stronger future results while Riverpoint closure improves operational efficiency.
8 Aug
Novanta closes its largest acquisition. Largest acquisition closure marks a major strategic move with potential to significantly alter company trajectory and investor sentiment.
7 Aug
Novanta Inc posted record cash flow for Q2 2026 and raised full-year guidance. Record cash flow and raised guidance signal stronger financial outlook likely to lift valuation and investor sentiment.
Novanta Inc. (NOVT) shared highlights from its Q2 earnings call covering financial results and operations. Q2 earnings highlights can shift investor views on financial performance and near-term outlook.
6 Aug
Novanta Inc. reports increased bookings that reinforce broadening organic momentum across its operations and markets. Increased bookings point to improved future revenue visibility and organic growth for the company.
5 Aug
Novanta exceeded Q2 CY2026 sales estimates and issued strong full-year sales guidance. Q2 sales beat paired with upbeat annual guidance signals stronger revenue trajectory and positive investor sentiment.
Novanta exceeded Q2 earnings and revenue estimates. Q2 earnings beat may lift near-term stock price and sentiment without altering long-term trajectory.
Novanta Inc. announced its financial results for the second quarter of 2026. Quarterly financial results release delivers performance metrics that can shift near-term investor views and trading activity.
27 Jul
Novanta Inc. completes acquisition of Riverpoint Medical. Acquisition marks major strategic expansion for Novanta.
9 Jun
Novanta Inc. acquires Riverpoint Medical for $1.45 billion. The $1.45 billion acquisition marks a major strategic expansion with significant effects on operations and positioning.
Novanta Inc. announces $300 million private placement. $300 million private placement delivers major capital infusion that alters financial structure and investor positioning.
Novanta Inc. acquires Riverpoint Medical. Acquisition marks major strategic expansion strengthening Novanta's medical device portfolio and market position.
20 May
Novanta reported Q1 results in its earnings call and fielded top analyst questions on financials, growth outlook, margins and market demand. Quarterly earnings call supplies updated guidance and analyst scrutiny that can shift near-term sentiment and valuation but rarely alters long-term trajectory.
16 May
Novanta Inc. posts Q1 growth fueled by AI-driven demand and new products, despite ongoing margin pressures. AI demand and new products signal major growth drivers likely to reshape Novanta's trajectory and investor outlook.
15 May
Novanta Inc. (NOVT) beat analyst earnings forecasts, prompting analysts to update their models with revised targets. Beating earnings expectations drives positive investor sentiment and analyst upgrades, significantly impacting stock performance and valuation.
13 May
Novanta Inc. (NOVT) earnings preview highlights expectations for revenue growth, adjusted EBITDA margins, EPS, and forward guidance amid supply chain issues and market softness in medical and advanced industrial segments. Earnings previews shape investor expectations on financial metrics and guidance, potentially swaying short-term market sentiment without transformative shifts.
12 May
Novanta Inc. (NOVT) released Q1 2026 earnings call transcript detailing financial results, operational updates, and forward guidance. Q1 2026 earnings transcript discloses financial performance and strategic outlook, poised to significantly sway investor sentiment and NOVT's trajectory.
Novanta Inc. (NOVT) reported strong revenue growth in Q1 2026 earnings call highlights, navigating geopolitical challenges successfully. Strong revenue growth in Q1 2026 despite geopolitical headwinds signals robust financial performance, likely driving positive investor sentiment and stock trajectory.
Novanta Inc. (NOVT) beat earnings expectations and issued stronger-than-expected forward guidance, prompting a detailed valuation reassessment amid positive market implications. Earnings beat and strong guidance shift signal robust financial health and growth prospects, significantly impacting NOVT's valuation and market performance.
Novanta Inc. released Q1 earnings call highlights, detailing financial results, revenue growth, profitability metrics, and forward guidance amid strong demand in medical and industrial robotics sectors. Q1 earnings highlights disclose key financial performance and outlook that can drive significant shifts in investor sentiment and stock trajectory.
Novanta Inc. released Q1 2026 earnings call summary detailing financial results, segment performance, and forward guidance. Quarterly earnings disclosures shape investor expectations and directly influence stock valuation and trajectory.
11 May
Novanta (NASDAQ:NOVT) surprised investors with strong Q1 CY2026 sales results. Q1 sales surprise signals major positive shift in financial performance and boosts investor sentiment.
Novanta Inc. announced financial results for the first quarter 2026. Quarterly earnings announcements like Q1 2026 results directly impact financial performance metrics, investor sentiment, and stock trajectory.
Novanta Inc. (NOVT) Q1 earnings and revenues surpassed analyst estimates. Q1 earnings beat positively influences financial performance and investor sentiment without fundamentally altering long-term trajectory.